informaworld logo
HOME . ABOUT US . CONTACT US 		HELP . PUBLISH WITH US . LIBRARIANS 
ebooks logo journals logo reference works logo abstract databases logo
bullet  SIGN IN Register | Why Register? | Got a Voucher? alerts   marked lists   shopping cart 
Advert: Informa Healthcare - http://www.informahealthcare.com

informaworld

HOME   |   SEARCH   |   BROWSE
    Issues List       Latest Issue       Forthcoming Articles       Volume 50 Issue 9       Subscribe      
<< earliestearliest   < prevprev   Issue listissues   next >next   latest >>latest
Publisher Logo Publication Cover
Search within this journal

Leukemia and Lymphoma, Volume 50 Issue 9 2009

Leukemia and Lymphoma is moving!
ISSN: 1029-2403 (electronic) 1042-8194 (paper)
Publication Frequency: 12 issues per year
Viewing the Journal: Select the initial letter of your research topic from the list below, or enter your search term on the left.
Sort by: Title | Page | Author
< Previous • 1 • 2 • Next >
View new articles ahead of the print edition
select-down Click for help
Commentaries
Stem-cell dose for allogeneic hematopoietic stem cell transplantation in hematological malignancies: is more better?
Avichai Shimoni; Arnon Nagler
Pages 1395 – 1396
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Are kinases factors in core binding factor leukemia?
Jeffrey R. Andolina; Seth J. Corey
Pages 1397 – 1398
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Bendamustine in chronic lymphocytic leukemia: the future is combination therapy
Jonathan W. Friedberg
Pages 1399 – 1400
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
FCGR3A polymorphism story: a new piece of the puzzle
Guillaume Cartron
Pages 1401 – 1402
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Molecular determinants of prognosis in acute myeloid leukemia (AML) with normal karyotype
Ulrike Bacher; Claudia Haferlach
Pages 1403 – 1405
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Reviews
Predicting transformation in follicular lymphoma
Daphne de Jong; Jan Paul de Boer
Pages 1406 – 1411
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Advances in mobilization for the optimization of autologous stem cell transplantation
Julie M. Vose;  Anthony D. Ho;  Bertrand Coiffier;  Paolo Corradini;  Issa Khouri;  Anna Sureda;  Koen Van Besien; John Dipersio
Pages 1412 – 1421
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Paraproteinemic neuropathy
Saša A. Živković;  David Lacomis; Suzanne Lentzsch
Pages 1422 – 1433
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Original Articles: Clinical
Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation
Jayesh Mehta;  Olga Frankfurt;  Jessica Altman;  Andrew Evens;  Martin Tallman;  Leo Gordon;  Stephanie Williams;  Jane Winter;  Jairam Krishnamurthy;  Sara Duffey;  Veerpal Singh;  Richard Meagher;  David Grinblatt;  Lynne Kaminer; Seema Singhal
Pages 1434 – 1441
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Toxicity of a second autologous peripheral blood stem cell transplant in patients with relapsed or recurrent multiple myeloma
Julianna Aleathea Burzynski;  Juan J. Toro;  Rakhi Chhaganbhai Patel;  Shuko Lee;  Rebecca Elizabeth Greene;  Jose Leonel Ochoa-Bayona;  Christopher Raymond Frei; Cesar O. Freytes
Pages 1442 – 1447
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome
Jana Marková;  Zuzana Trnková;  Petra Michková;  Jacqueline Maaloufová;  Jan Starý;  Petr Cetkovský; Jiří Schwarz
Pages 1448 – 1460
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome
Lingyun Wu;  Xiao Li;  Jiying Su;  Chunkang Chang;  Qi He;  Xi Zhang;  Li Xu;  Luxi Song; Quan Pu
Pages 1461 – 1467
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Bendamustine/mitoxantrone/rituximab: a short remission induction chemoimmunotherapy for elderly patients with relapsed or refractory chronic lymphocytic leukemia
Rudolf Weide;  Ulrike Mergenthaler;  Vera Friesenhahn;  Kristina Kleboth;  Jochen Heymanns;  Jörg Thomalla; Hubert Köppler
Pages 1468 – 1474
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Long term outcome of localized aggressive non-Hodgkin lymphoma treated with a short weekly chemotherapy regimen (doxorubicin, cyclophosphamide, bleomycin, vincristine, and prednisone) and involved field radiotherapy: result of a Gruppo Italiano Multiregionale per lo Studio dei Linfomi e Leucenie (GIMURELL) study
Maria Giuseppina Cabras;  Angela Maria Mamusa;  Umberto Vitolo;  Roberto Freilone R.;  Paolo Dessalvi;  Lorella Orsucci;  Anna Tonso;  Alessandro Levis;  Marina Liberati;  Giancarlo Lay; Emanuele Angelucci
Pages 1475 – 1481
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
The negative prognostic significance of positive direct antiglobulin test in Chinese patients with chronic lymphocytic leukemia
Wei Xu;  Jian-Yong Li;  Kou-Rong Miao;  Xin Cao;  Qiong Liu;  Lei Fan;  Chun Qiao; Yu-Jie Wu
Pages 1482 – 1487
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Haploidentical hematopoietic stem-cell transplantation for non-Hodgkin lymphoma with bone marrow involvement
Heng-Xiang Wang;  Hong-Min Yan;  Jing Liu;  Lian-Ning Duan;  Zhi-Dong Wang;  Ling Zhu;  Mei Xue; Zi-Kuan Guo
Pages 1488 – 1493
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Original Articles: Research
Immunoglobulin G Fc receptor polymorphisms do not correlate with response to chemotherapy or clinical course in patients with follicular lymphoma
Wen-Kai Weng; Ronald Levy
Pages 1494 – 1500
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98)
R. Zenhäusern;  S.-F. Hsu Schmitz;  M. Solenthaler;  D. Heim;  S. Meyer-Monard;  U. Hess;  L. Leoncini;  M. Bargetzi;  B. Rufener;  A. Tobler; For the Swiss Group for Clinical Cancer Research (SAKK)
Pages 1501 – 1511
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Low p14ARF expression in de novo acute myeloid leukemia with normal karyotype is associated with poor survival
Esbjörn Paul;  Bertil Uggla;  Stefan Deneberg;  Sofia Bengtzen;  Monica Hermansson;  Ingrid Dahlman;  Richard Rosenquist;  Klas G. Wiman; Hareth Nahi
Pages 1512 – 1518
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
select-up

Privacy Policy | Terms & Conditions | Accessibility | RSS
FAQs in: English . Français . Español . 中文（简体和繁體）
© 2009 Informa plc